- Home
- DAWN vs BHLB Comparison
DAWN vs BHLB Comparison
Compare DAWN & BHLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- BHLB
- Stock Information
- Founded
- DAWN 2018
- BHLB 1846
- Country
- DAWN United States
- BHLB United States
- Employees
- DAWN N/A
- BHLB N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- BHLB Banks
- Sector
- DAWN Health Care
- BHLB Finance
- Exchange
- DAWN Nasdaq
- BHLB Nasdaq
- Market Cap
- DAWN 658.9M
- BHLB 1.1B
- IPO Year
- DAWN 2021
- BHLB 2000
- Fundamental
- Price
- DAWN $7.02
- BHLB $26.32
- Analyst Decision
- DAWN Strong Buy
- BHLB Hold
- Analyst Count
- DAWN 7
- BHLB 5
- Target Price
- DAWN $31.57
- BHLB $32.70
- AVG Volume (30 Days)
- DAWN 1.3M
- BHLB 519.5K
- Earning Date
- DAWN 07-29-2025
- BHLB 07-24-2025
- Dividend Yield
- DAWN N/A
- BHLB 2.71%
- EPS Growth
- DAWN N/A
- BHLB 392.17
- EPS
- DAWN N/A
- BHLB 2.46
- Revenue
- DAWN $161,922,000.00
- BHLB $431,403,000.00
- Revenue This Year
- DAWN $17.98
- BHLB $31.27
- Revenue Next Year
- DAWN $49.50
- BHLB $78.77
- P/E Ratio
- DAWN N/A
- BHLB $10.64
- Revenue Growth
- DAWN N/A
- BHLB 33.05
- 52 Week Low
- DAWN $6.08
- BHLB $22.27
- 52 Week High
- DAWN $16.76
- BHLB $32.36
- Technical
- Relative Strength Index (RSI)
- DAWN 58.34
- BHLB 58.05
- Support Level
- DAWN $6.52
- BHLB $26.28
- Resistance Level
- DAWN $7.24
- BHLB $26.96
- Average True Range (ATR)
- DAWN 0.26
- BHLB 0.59
- MACD
- DAWN 0.07
- BHLB 0.16
- Stochastic Oscillator
- DAWN 78.37
- BHLB 76.64
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About BHLB Berkshire Hills Bancorp Inc.
Berkshire Hills Bancorp Inc is a holding company. It provides Commercial Banking, Retail Banking, Consumer Lending, Private Banking and Wealth Management services.